UNSPSC 51434801: Neldazosin

This classification denotes an antihypertensive agent with the molecular formula C18H25N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G3E7RO42MB, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(3-hydroxybutyryl)piperazine but generally known as neldazosin, which bears US NIH Compound Identifier 65908. European Medicines Agency schedules Neldazosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09184MIG.

UNSPSC 51434801 Neldazosin (Commodity tier) encompasses pharmaceutical products that state and local governments procure for emergency medical services, public health programs, and cooperative purchasing networks. The code covers individual active pharmaceutical ingredients and formulated medications supplied under standing contracts or emergency procurements. Recent solicitations show state and local buyers acquiring advanced life support medications (epinephrine, adenosine, diltiazem, labetalol) for fire rescue operations, generic multi-source pharmaceuticals through cooperative purchasing alliances, and exploring direct-to-manufacturer prescription fulfillment models to improve cost management and supply chain efficiency. Issuing bodies span city fire departments, state health and human services agencies, and multistate cooperative purchasing organizations. Tampa Fire Rescue and the Texas Health and Human Services Commission represent typical end-users; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) demonstrates the role of regional purchasing consortia that aggregate demand across participating state and local members.

Activity concentrates in Florida, Texas, and Minnesota based on recent postings. The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications with a response deadline of April 8, 2026, requiring 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with an estimated contract value of $40,000 and a Small Local Business Enterprise (SLBE) sheltered market designation offering a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP for Generic Multi Source Pharmaceuticals and OTC Products, due March 26, 2026, requiring vendors to supply through three authorized wholesalers and covering multistate and local government facilities in Minnesota and Oregon. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs as a precursor to formal solicitation. All three solicitations require FDA compliance, cGMP certification where applicable, Safety Data Sheets, and expiration-date assurances ranging from six months to one year of shelf life at delivery.